⏳ Fetching live dividend data...
Home › Calculator › ORTX Dividend Calculator 2026
Orchard Therapeutics plc · NASDAQ
Price: $16.70 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ORTX → $31.0K in 10 years · $276.22/month
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the treatment of adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company's clinical development products comprise OTL-101 for the treatment of ADA-SCID; OTL-200 to treat metachromatic leukodystrophy; OTL-103 for the treatment of Wiskott-Aldrich syndrome; OTL-102 for X-linked chronic granulomatous disease; and OTL-300 for transfusion-dependent beta-thalassemia. Its preclinical programs include OTL-203 for mucopolysaccharidosis type I, OTL-201 for mucopolysaccharidosis type MPS-IIIA, and OTL-202 for mucopolysaccharidosis type IIIB. It has a strategic collaboration agreement with Pharming Group N.V. for research, development, manufacturing, and commercialization of OTL-105, an investigational ex vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. The company was formerly known as Orchard Rx Limited. Orchard Therapeutics plc was founded in 2015 and is headquartered in London, the United Kingdom.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ORTX position with:
Real after-tax yield depends on where you live and how you hold ORTX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 11.98% | 9.18% | $1,198 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 10.18% | 7.38% | $1,018 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 9.58% | 6.78% | $958 / yr |
| 🇬🇧 UK ISA | 0% | 11.98% | 9.18% | $1,198 / yr |
| 🇬🇧 UK Taxable | 8.75% | 10.93% | 8.13% | $1,093 / yr |
| 🇨🇦 TFSA | 0% | 11.98% | 9.18% | $1,198 / yr |
| 🇨🇦 CA Taxable | 25% | 8.98% | 6.18% | $899 / yr |
| 🇦🇺 Super (pension) | 15% | 10.18% | 7.38% | $1,018 / yr |
| 🇦🇺 AU Taxable | 30% | 8.39% | 5.59% | $839 / yr |
| 🇩🇪 DE Taxable | 26.375% | 8.82% | 6.02% | $882 / yr |
| 🇫🇷 FR Taxable | 30% | 8.39% | 5.59% | $839 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
ORTX pays quarterly — 4 times per year. Next ex-div: TBD.
How ORTX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ORTX sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2024-01-24 | 46,000 | $0.47 | $21.9K | ||
| D-Return | 2024-01-24 | 105,000 | $0.49 | $52.0K | ||
| D-Return | 2024-01-24 | 46,000 | $0.47 | $21.9K | ||
| D-Return | 2024-01-24 | 105,000 | $0.49 | $52.0K | ||
| D-Return | 2024-01-24 | 44,391 | $16.00 | $710.3K | ||
| D-Return | 2024-01-24 | 335,000 | $0.46 | $153.8K | ||
| D-Return | 2024-01-24 | 405,590 | $0.46 | $188.2K | ||
| D-Return | 2024-01-24 | 179,390 | $0.58 | $104.0K | ||
| D-Return | 2024-01-24 | 92,081 | $16.00 | $1.47M | ||
| D-Return | 2024-01-24 | 46,000 | $0.47 | $21.9K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ORTX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →